HANCOCK JAFFE LABORATORIES I's ticker is HJLI and the CUSIP is 41015N106. A total of 4 filers reported holding HANCOCK JAFFE LABORATORIES I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $20,000 | +400.0% | 52,695 | +580.4% | 0.00% | – |
Q4 2019 | $4,000 | 0.0% | 7,745 | +59.7% | 0.00% | – |
Q3 2019 | $4,000 | -60.0% | 4,849 | -26.2% | 0.00% | – |
Q1 2019 | $10,000 | -54.5% | 6,567 | -56.9% | 0.00% | – |
Q4 2018 | $22,000 | +2100.0% | 15,230 | +4379.4% | 0.00% | – |
Q2 2018 | $1,000 | – | 340 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gladstone Institutional Advisory LLC | 40,000 | $15,000 | 0.00% |
Virtu Financial LLC | 15,788 | $6,000 | 0.00% |
UBS Group AG | 52,695 | $20,000 | 0.00% |
OSAIC HOLDINGS, INC. | 15,000 | $6,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 72 | $0 | 0.00% |
NORTHERN TRUST CORP | 19,220 | $7,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
TWO SIGMA SECURITIES, LLC | 15,451 | $6,000 | 0.00% |
Renaissance Technologies | 270,118 | $104,000 | 0.00% |